TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Immunbutiken AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
178
|
213
|
210 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
19
|
-6
|
4 |
| EBITDA |
19
|
-6
|
4 |
| Total assets |
64
|
60
|
63 |
| Current assets |
64
|
60
|
63 |
| Current liabilities |
27
|
38
|
25 |
| Equity capital |
34
|
20
|
34 |
| - share capital |
9
|
9
|
9 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
53.1%
|
33.3%
|
54.0% |
| Turnover per employee |
89
|
106
|
105 |
| Profit as a percentage of turnover |
10.7%
|
-2.8%
|
1.9% |
| Return on assets (ROA) |
29.7%
|
-10.0%
|
6.3% |
| Current ratio |
237.0%
|
157.9%
|
252.0% |
| Return on equity (ROE) |
55.9%
|
-30.0%
|
11.8% |
| Change turnover |
-27
|
3
|
-77 |
| Change turnover % |
-13%
|
1%
|
-27% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.